Insider Shareholders with Direct Ownership of Gossamer Bio, Inc. (GOSS)
This section provides a comprehensive overview of the insiders with direct ownership of Gossamer Bio, Inc. (GOSS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Gossamer Bio, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Waage Christian
EVP, Tech Ops and Admin |
170,000 | 22,642 | 710,934 $1.76 Million | 5 |
Oct 01, 2025
Added 14.95%
|
Faheem Hasnain
President & CEO |
600,000 | 42,207 | 557,793 $1.38 Million | 4 |
Oct 01, 2025
Added 43.96%
|
Richard Aranda
Chief Medical Officer |
177,500 | 30,493 | 369,356 $916,002 | 10 |
Oct 01, 2025
Added 30.55%
|
Bryan Giraudo
COO/CFO |
226,250 | 22,642 | 273,987 $679,487 | 5 |
Oct 01, 2025
Added 39.81%
|
Luisa Salter Cid
Chief Scientific Officer |
45,000 | 5,491 | 206,065 $511,041 | 2 |
Mar 23, 2021
Reduced 2.6%
|
Caryn Peterson
EVP, Regulatory Affairs |
135,820 | 24,995 | 174,833 $433,585 | 7 |
Oct 01, 2025
Added 41.69%
|
Robert Paul Smith Jr
Chief Commercial Officer |
162,500 | 0 | 162,500 $403,000 | 1 |
Oct 01, 2025
Added 50.0%
|
Laura Carter
Chief Scientific Officer |
42,754 | 28,354 | 76,263 $189,132 | 9 |
Mar 16, 2023
Reduced 7.33%
|
Sandra Milligan
Director |
26,050 | 0 | 58,050 $143,964 | 1 |
Aug 19, 2025
Added 30.98%
|